Literature DB >> 3974967

Poor prognosis in patients with adenosquamous cell carcinoma of the cervix.

D G Gallup, R H Harper, R J Stock.   

Abstract

From 1 July 1974 to 31 December 1982, 127 patients with primary carcinoma of the cervix were assessed to determine the prognosis of patients with adenosquamous cell carcinoma. Of all patients, 34 are dead of disease for an overall corrected survival rate of 73.2%. The survival of 20 patients with adenosquamous cell carcinoma is 20%. Seventy-five percent of the adenosquamous cell patients had stage IB lesions. When patients with adenosquamous cell carcinoma were compared with patients with squamous cell carcinoma or adenocarcinoma, there was a statistically significant decrease in survival. Patients with adenosquamous cell carcinoma were relatively young with a mean age of 41.1 years. A normal appearing cervix was noted in 30% of all patients with adenosquamous cell carcinoma. The majority of adenosquamous cell patients (87.5%) dead from cancer had distant metastases. This report emphasizes that, independent of stage, adenosquamous cell cervical carcinoma is an extremely aggressive neoplasm and carries a poor prognosis.

Entities:  

Mesh:

Year:  1985        PMID: 3974967

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  9 in total

Review 1.  HPV-related squamous cell carcinoma variants in the head and neck.

Authors:  Samir K El-Mofty
Journal:  Head Neck Pathol       Date:  2012-07-03

2.  Expression of epithelial membrane and 3-fucosyl-N-acetyllactosamine antigens in cervix uteri with particular reference to adenocarcinoma in situ.

Authors:  T P Rollason; P Byrne; A Williams; G Brown
Journal:  J Clin Pathol       Date:  1988-05       Impact factor: 3.411

3.  Leptomeningeal metastasis of poorly differentiated uterine cervical adenosquamous carcinoma following reirradiation to metastatic vertebrae: A case report.

Authors:  Yueh-Feng Lu; Vai Hong Fong; Wen-Yih Wu; Li-Ying Wang; Chen-Hsi Hsieh
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

4.  Changing the Prognosis of Metastatic Cervix Uteri Adenosquamous Carcinoma through a Multimodal Approach: A Case Report.

Authors:  Mihai Teodor Georgescu; Dragos Eugen Georgescu; Teodor Florin Georgescu; Luiza Georgia Serbanescu
Journal:  Case Rep Oncol       Date:  2020-12-23

5.  Fertility-preserving surgery in patients with early stage cervical carcinoma.

Authors:  Spyridon Kardakis
Journal:  ISRN Oncol       Date:  2012-12-18

6.  Human papillomavirus types 16 and 18 and the prognosis of patients with stage I cervical cancer.

Authors:  Rossana de Araújo Catão Zampronha; Ruffo Freitas-Junior; Eddie Fernando Candido Murta; Márcia Antoniazi Michelin; Aline Almeida Barbaresco; Sheila Jorge Adad; Amaurillo Monteiro de Oliveira; Amanda B Rassi; Glória Jabur Bittar Oton
Journal:  Clinics (Sao Paulo)       Date:  2013-06       Impact factor: 2.365

7.  Prognostic value of histopathology and trends in cervical cancer: a SEER population study.

Authors:  Vincent Vinh-Hung; Claire Bourgain; Georges Vlastos; Gábor Cserni; Mark De Ridder; Guy Storme; Anne-Thérèse Vlastos
Journal:  BMC Cancer       Date:  2007-08-23       Impact factor: 4.430

8.  Treatment outcomes of high-dose-rate intracavitary brachytherapy for cervical cancer: a comparison of Ir-192 versus Co-60 sources.

Authors:  Thanatip Tantivatana; Kanisa Rongsriyam
Journal:  J Gynecol Oncol       Date:  2018-09       Impact factor: 4.401

9.  Prognostic value of HPV DNA status in cervical cancer before treatment: a systematic review and meta-analysis.

Authors:  Ping Li; Yue Tan; Li-Xia Zhu; Li-Na Zhou; Ping Zeng; Qin Liu; Min-Bin Chen; Ye Tian
Journal:  Oncotarget       Date:  2017-06-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.